ReviewInternational journal of molecular sciences2019

Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy.

Jianguang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.